Consideration of platelet function disorders in patients with reduced VWF levels

Haemophilia

Volumn 14, Issue 5, 2008, Pages 1131-1132

  Millar, Carolyn M ^a   Riddell, A F ^a   Tuddenham, E G ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

BLEEDING DISORDER; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FALSE NEGATIVE RESULT; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

BLOOD PLATELET DISORDERS; HUMANS; PLATELET FUNCTION TESTS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 51249097818     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01818.x     Document Type: Letter

References (5)

1. Nichols WL, Hultin MB, James AH et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.
2. Sadler JE. von Willebrand factor: Two sides of a coin. J Thromb Haemost 2005; 3: 1702-9.
3. Bolton-Maggs PH, Chalmers EA, Collins PW et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135: 603-33.
4. Favaloro EJ. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: A review of analytical variables, benefits and limitations. Haemophilia 2001; 7: 170-9.
5. Quiroga T, Goycoolea M, Munoz B et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: Comparative study in 148 patients. J Thromb Haemost 2004; 2: 892-8.